NPTH.V NeuPath Health Inc

Healthcare Health Care Providers & Services TSX Venture Exchange
0.5600 CAD
Close of Nov 7, 2026
0.3500 0.6800
Market cap
CAD 31.9M
P/E
28.0x
P/B
1.34x
ROE
16.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is NPTH.V undervalued?

Graham number
Price0.5600
Graham value0.4335
Premium29.2%

NPTH.V trades 29.2% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NeuPath Health Inc fundamental analysis

No fundamental analysis for NeuPath Health Inc yet.

NeuPath Health Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NeuPath Health Inc

NeuPath Health Inc. provides chronic pain management services in Canada. It operates a network of medical clinics in Ontario and Alberta that offer assessments and rehabilitation services to patients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions. The company also provides workplace health services and independent medical assessments to employers and disability insurers, as well as legal practices through a network of health care p…

Full company profile